Legal Representation
Attorney
Jenevieve Maerker
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 15, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Apr 15, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Sep 20, 2019 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Sep 20, 2019 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Sep 20, 2019 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Sep 18, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 9, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 2, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for human use; pharmaceuticals for the treatment of cancer, tumors, and oncological diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005